Publicacions en col·laboració amb investigadors/es de Fundación Jiménez Díaz (9)

2022

  1. Beta-3 adrenergic receptor overexpression reverses aortic stenosis–induced heart failure and restores balanced mitochondrial dynamics

    Basic Research in Cardiology, Vol. 117, Núm. 1

2020

  1. A Network of Macrophages Supports Mitochondrial Homeostasis in the Heart

    Cell, Vol. 183, Núm. 1, pp. 94-109.e23

  2. The pharmaceutical solvent N-methyl-2-pyrollidone (NMP) attenuates inflammation through Krüppel-like factor 2 activation to reduce atherogenesis

    Scientific Reports, Vol. 10, Núm. 1

2018

  1. Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction

    Journal of Cardiovascular Translational Research, Vol. 11, Núm. 4, pp. 310-318

  2. Spanish National Hip Fracture Registry (SNHFR): a description of its objectives, methodology and implementation

    Revista Espanola de Geriatria y Gerontologia, Vol. 53, Núm. 4, pp. 188-195

2016

  1. Anti-JC virus seroprevalence in a Spanish multiple sclerosis cohort JC virus seroprevalence in Spain

    Journal of the Neurological Sciences, Vol. 365, pp. 16-21

  2. Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension

    Basic Research in Cardiology, Vol. 111, Núm. 4

2008

  1. Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness

    Journal of Antimicrobial Chemotherapy, Vol. 62, Núm. 6, pp. 1234-1240

2003

  1. Effect of AT 1 receptor blockade on hepatic redox status in SHR: Possible relevance for endothelial function?

    American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 285, Núm. 3 54-3